Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women
- 1 October 1992
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 66 (4) , 744-747
- https://doi.org/10.1038/bjc.1992.350
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Incidence and clinical characteristics of hereditary disorders associated with venous thrombosisAmerican Journal of Hematology, 1991
- Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.BMJ, 1991
- Fibrinogen as a major risk factor in cardiovascular diseaseTrends in Pharmacological Sciences, 1990
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer and Clinical Oncology, 1990
- Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- TAMOXIFEN AND ARTERIAL THROMBOSISThe Lancet, 1985
- Antithrombin III: Referenzwerte mit einem chromogenen Substrat (Chromozym TH)Annals of Hematology, 1981
- Characterization of Serum Fibrinogen and Fibrin Fragments Produced during Disseminated Intravascular CoagulationBritish Journal of Haematology, 1978
- TAMOXIFEN AND THROMBOSISThe Lancet, 1978
- Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetrationImmunochemistry, 1971